Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

vascular endothelial growth factor

  • You have access
    Elevated Preoperative Serum Vascular Endothelial Growth Factor Does Not Predict Poor Outcomes in Curatively Resected Non-metastatic Colorectal Cancer Treated Without Neoadjuvant Therapy
    NOZOMU NAKAI, ANRI MAEDA, TAKESHI YANAGITA, TAKUYA SUZUKI, YUZO MAEDA, TAKAHISA HIROKAWA, KAZUYOSHI SHIGA, MASAYASU HARA, HIROKI TAKAHASHI, RYO OGAWA, YOICHI MATSUO and SHUJI TAKIGUCHI
    Anticancer Research May 2023, 43 (5) 2333-2341; DOI: https://doi.org/10.21873/anticanres.16398
  • You have access
    Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    YUJI NOJIMA, KATSUHIKO SHIMIZU, SHINSUKE SAISHO, AI MAEDA, TAKESHI KUROSAKI, KOJI KUROSE, TORU OGA, MIKIO OKA and MASAO NAKATA
    Anticancer Research November 2021, 41 (11) 5469-5475; DOI: https://doi.org/10.21873/anticanres.15359
  • You have access
    Calcitriol Combined With Platinum-based Chemotherapy Suppresses Growth and Expression of Vascular Endothelial Growth Factor of SKOV-3 Ovarian Cancer Cells
    JU-HYUN KIM, WOOK HA PARK, DONG HOON SUH, KIDONG KIM, JAE HONG NO and YONG BEOM KIM
    Anticancer Research June 2021, 41 (6) 2945-2952; DOI: https://doi.org/10.21873/anticanres.15076
  • You have access
    Plasma Levels and Tissue Expression of Selected Cytokines, Metalloproteinases and Tissue Inhibitors in Patients With Cervical Cancer
    IWONA SIDORKIEWICZ, BARBARA PISKÓR, EMILIA DĄBROWSKA, KATARZYNA GUZIŃSKA-USTYMOWICZ, ANNA PRYCZYNICZ, MONIKA ZBUCKA-KRĘTOWSKA and SŁAWOMIR ŁAWICKI
    Anticancer Research November 2019, 39 (11) 6403-6412; DOI: https://doi.org/10.21873/anticanres.13854
  • You have access
    Associations Between Gene Polymorphisms of Vascular Endothelial Growth Factor and Prostate Cancer
    HENRIETA DROBKOVÁ, JANA JUREČEKOVÁ, MONIKA KMEŤOVÁ SIVOŇOVÁ, JANA MAZUCHOVÁ, MICHAELA ŠKORVANOVÁ, MIROSLAVA ŠARLINOVÁ, ERIKA HALAŠOVÁ and JÁN KLIMENT
    Anticancer Research June 2019, 39 (6) 2903-2909; DOI: https://doi.org/10.21873/anticanres.13419
  • You have access
    Functional Characterization of VEGF- and FGF-induced Tumor Blood Vessel Models in Human Cancer Xenografts
    YUSAKU HORI, KEN ITO, SHUSEI HAMAMICHI, YOICHI OZAWA, JUNJI MATSUI, IZUMI O. UMEDA and HIROFUMI FUJII
    Anticancer Research December 2017, 37 (12) 6629-6638;
  • You have access
    Evaluation of Natriuretic Peptide in Non-small Cell Lung Cancer Patients Treated with Bevacizumab Together with Carboplatin–Paclitaxel: A Prospective Study
    TOMOYUKI OTSUKA, TAKASHI NOJIRI, SEIGO MINAMI, HIROSHI HOSODA, MUNEYOSHI KUROYAMA, HARUHIKO HIRATA, KAORI NAKANISHI, SUGURU YAMAMOTO, KIYOSHI KOMUTA, KENJI KANGAWA and TAKASHI KIJIMA
    Anticancer Research July 2017, 37 (7) 3505-3512;
  • You have access
    Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 Cases
    NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE
    Anticancer Research July 2017, 37 (7) 3711-3715;
  • You have access
    Targeting the Unfolded Protein Response as a Potential Therapeutic Strategy in Renal Carcinoma Cells Exposed to Cyclosporine A
    SANDRA BODEAU, CHLOÉ SAUZAY, RÉMY NYGA, CHRISTOPHE LOUANDRE, VÉRONIQUE DESCAMPS, CATHERINE FRANÇOIS, CORINNE GODIN, GABRIEL CHOUKROUN and ANTOINE GALMICHE
    Anticancer Research March 2017, 37 (3) 1049-1057;
  • You have access
    Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin–Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion
    MOTOHIRO TAMIYA, AKIHIRO TAMIYA, TOMOMI YASUE, KEIKO NAKAO, NAOKI OMACHI, TAKAYUKI SHIROYAMA, ERIKO TANI, MASANARI HAMAGUCHI, NAOKO MORISHITA, HIDEKAZU SUZUKI, NORIO OKAMOTO, KYOICHI OKISHIO, TOMOYA KAWAGUCHI, SHINJI ATAGI and TOMONORI HIRASHIMA
    Anticancer Research June 2016, 36 (6) 2939-2944;

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire